Annual report pursuant to Section 13 and 15(d)

Income Taxes - Additional Information (Details)

v3.23.1
Income Taxes - Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Less valuation allowance $ 64,741 $ 51,454
Tax credit Carryforward, Amount 1,300  
Unrecognized tax benefits interest and penalties accrued 0 $ 0
Research and development credit carryforwards    
Tax credit Carryforward, Amount $ 2,800  
Orphan drug credit carryforwards    
Tax credit carryforward, expiration date Dec. 31, 2034  
Federal    
Operating Loss Carryforwards $ 155,200  
Operating loss carryforwards indefinitely amount 124,000  
Operating loss carryforwards remaining amount $ 31,200  
Operating loss carry forwards expiration period 2034  
State and Local    
Operating Loss Carryforwards $ 117,500  
Operating loss carryforwards indefinitely amount 300  
Operating loss carryforwards remaining amount $ 117,200  
Operating loss carry forwards expiration period 2034